Enzymlogic will be presenting its KINETICfinder® and COVALfinder® platforms at this 2-day event in Boston alongside our academic collaborator Professor Peter Tonge (Stony Brook University), a world expert in kinetics. The presentation will be featured on November 18th as part of the Hit Finding Technologies and Advancements session.
The Discovery US Congress 2022 will highlight the latest advancements in discovery biology, medicinal chemistry and drug design: including RNA based therapeutics, Targeted Protein Degradation or Hit Finding Technologies.
Don’t miss the opportunity to meet us in person and learn how our drug discovery services can bring you and your business great competitive advantage!